US FDA Struggles To Meet Goals As Drug Sponsors' Meeting Requests Rise
Executive Summary
The FDA did not expect to meet many FY 2018 goals for on-time scheduling of formal PDUFA meetings or issuing written responses in lieu of meetings.
You may also be interested in...
US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.
The COVID Boom: CBER Receives More INDs in One Quarter Than The Previous 30 Combined
Bubble was short-lived, but still could create workload problems for the US FDA as it navigates the end of the coronavirus pandemic.
PDUFA VII: US FDA Says Money Can’t Solve Meeting Problems
Mid-cycle meeting for some supplements cannot be accommodated without extending the goal date, the agency tells industry negotiators.